In order to improve the tumor-targeting drug delivery of EVs, Dr. Schiffelers et al. utilized hydrophobic insertion to decorate the surface of EVs with targeting ligand EGFR, which was conjugated to phospholipid–PEG derivatives (EGFR-PEG-PL) [124]. Here, EGFR is linked to neoplasm.